Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
February 22, 2023
Donafenib in hepatocellular carcinoma
Rusi Chen, Luca Ielasi, Alma di Carlo, et al.
Chinese Clinical Oncology
|
October 11, 2024
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma
Rusi Chen, Giovanni Monaco, Bernardo Stefanini, et al.
Expert Review of Anticancer Therapy
|
February 16, 2023
TKIs in combination with immunotherapy for hepatocellular carcinoma
Bernardo Stefanini, Luca Ielasi, Rusi Chen, et al.
Nutrients
|
February 10, 2024
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review
Ernestina Santangeli, Chiara Abbati, Rusi Chen, et al.
World Journal of Gastroenterology
|
February 5, 2026
Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials
Sara Ascari, Rusi Chen, Andrea De Sinno, et al.
Expert Review of Anticancer Therapy
|
February 6, 2025
Advancements in immunotherapy for hepatocellular carcinoma
Sara Ascari, Rusi Chen, Caterina Vivaldi, et al.
Nutrients
|
March 29, 2023
Effects of COVID-19 Pandemic on Metabolic Status and Psychological Correlates of a Cohort of Italian NAFLD Outpatients
Silvia Ferri, Bernardo Stefanini, Marta Minguzzi, et al.
Computers in Biology and Medicine
|
February 16, 2024
Thyroid ultrasound diagnosis improvement via multi-view self-supervised learning and two-stage pre-training
Jian Wang, Xin Yang, Xiaohong Jia, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 7, 2021
Clinical Score and Machine Learning-Based Model to Predict Diagnosis of Primary Aldosteronism in Arterial Hypertension
Fabrizio Buffolo, Jacopo Burrello, Alessio Burrello, et al.
Journal of Hepatocellular Carcinoma
|
March 23, 2026
HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients
Madalina-Gabriela Indre, Bernardo Stefanini, Maria Boe, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Drugs of Today (Barcelona, Spain : 1998)
|
February 22, 2023
Donafenib in hepatocellular carcinoma
Rusi Chen, Luca Ielasi, Alma di Carlo, et al.
Chinese Clinical Oncology
|
October 11, 2024
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma
Rusi Chen, Giovanni Monaco, Bernardo Stefanini, et al.
Expert Review of Anticancer Therapy
|
February 16, 2023
TKIs in combination with immunotherapy for hepatocellular carcinoma
Bernardo Stefanini, Luca Ielasi, Rusi Chen, et al.
Nutrients
|
February 10, 2024
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review
Ernestina Santangeli, Chiara Abbati, Rusi Chen, et al.
World Journal of Gastroenterology
|
February 5, 2026
Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials
Sara Ascari, Rusi Chen, Andrea De Sinno, et al.
Expert Review of Anticancer Therapy
|
February 6, 2025
Advancements in immunotherapy for hepatocellular carcinoma
Sara Ascari, Rusi Chen, Caterina Vivaldi, et al.
Nutrients
|
March 29, 2023
Effects of COVID-19 Pandemic on Metabolic Status and Psychological Correlates of a Cohort of Italian NAFLD Outpatients
Silvia Ferri, Bernardo Stefanini, Marta Minguzzi, et al.
Computers in Biology and Medicine
|
February 16, 2024
Thyroid ultrasound diagnosis improvement via multi-view self-supervised learning and two-stage pre-training
Jian Wang, Xin Yang, Xiaohong Jia, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 7, 2021
Clinical Score and Machine Learning-Based Model to Predict Diagnosis of Primary Aldosteronism in Arterial Hypertension
Fabrizio Buffolo, Jacopo Burrello, Alessio Burrello, et al.
Journal of Hepatocellular Carcinoma
|
March 23, 2026
HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients
Madalina-Gabriela Indre, Bernardo Stefanini, Maria Boe, et al.
Page
of 2